Skip to main content

Bellevue Group AG

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1674546 Zurich, V8

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$215,314,678
+$204,564,074 QoQ
Shares Held
278,674
+1900.8% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
5.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bellevue Group AG holds $2,583,944,637 across 59 Biotechnology names. REGN ranks #3 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
278,674 $215,314,678

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $215,314,678 278,674
2025-12-31 $10,750,604 13,928
2025-09-30 $8,466,098 15,057
2025-06-30 $14,040,600 26,744
2025-03-31 $18,090,142 28,523
2024-12-31 $22,375,709 31,412
2024-09-30 $28,148,002 26,776
2024-06-30 $33,945,115 32,297
2024-03-31 $6,811,541 7,077
2023-12-31 $9,405,607 10,709
2023-09-30 $12,294,199 14,939
2023-06-30 $11,731,602 16,327
2023-03-31 $12,584,697 15,316
2022-12-31 $11,311,520 15,678
2022-09-30 $11,978,760 17,389
2022-06-30 $10,478,961 17,727
2022-03-31 $63,053,357 90,280
2021-12-31 $58,769,251 93,060
2021-09-30 $64,397,203 106,410
2021-06-30 $59,015,336 105,660
2021-03-31 $16,938,412 35,800
2020-12-31 $13,382,147 27,700
2020-09-30 $11,195,600 20,000
2020-06-30 $14,406,315 23,100
2020-03-31 $9,326,339 19,100